Health Catalyst Inc (HCAT) CEO Daniel D. Burton Sold $3.7 million of Shares
- By insider
CEO of Health Catalyst Inc (30-Year Financial, Insider Trades) Daniel D. Burton (insider trades) sold 121,052 shares of HCAT on 08/25/2020 at an average price of $30.39 a share. The total sale was $3.7 million.
Health Catalyst Inc has a market cap of $1.22 billion; its shares were traded at around $30.73 with and P/S ratio of 6.25. GuruFocus has detected 1 severe warning sign with Health Catalyst Inc. .
CEO Recent Trades:
CEO Daniel D. Burton sold 121,052 shares of HCAT stock on 08/25/2020 at the average price of $30.39. The price of the stock has increased by 1.12% since.
CEO Daniel D. Burton sold 122,868 shares of HCAT stock on 08/21/2020 at the average price of $32.22. The price of the stock has decreased by 4.62% since.
CEO Daniel D. Burton sold 149,687 shares of HCAT stock on 08/19/2020 at the average price of $32.52. The price of the stock has decreased by 5.5% since.
CEO Daniel D. Burton sold 171,612 shares of HCAT stock on 08/17/2020 at the average price of $31.82. The price of the stock has decreased by 3.43% since.
CEO Daniel D. Burton sold 200,570 shares of HCAT stock on 07/31/2020 at the average price of $35.37. The price of the stock has decreased by 13.12% since.
CFO Recent Trades:
CFO James Patrick Jr. Nelli sold 64,547 shares of HCAT stock on 08/17/2020 at the average price of $31.69. The price of the stock has decreased by 3.03% since.
Directors and Officers Recent Trades:
General Counsel Daniel H. Orenstein sold 5,000 shares of HCAT stock on 08/14/2020 at the average price of $31.45. The price of the stock has decreased by 2.29% since.
Director Anita Pramoda sold 4,000 shares of HCAT stock on 08/14/2020 at the average price of $31.46. The price of the stock has decreased by 2.32% since.
COO Paul Horstmeier sold 10,800 shares of HCAT stock on 08/03/2020 at the average price of $35.51. The price of the stock has decreased by 13.46% since.
Chief People Officer Linda Llewelyn sold 2,242 shares of HCAT stock on 08/03/2020 at the average price of $35.46. The price of the stock has decreased by 13.34% since.
Chief Technology Officer Dale Sanders sold 27,500 shares of HCAT stock on 08/03/2020 at the average price of $35.52. The price of the stock has decreased by 13.49% since.
For the complete insider trading history of HCAT, click here
.This article first appeared on GuruFocus.